MedPath

R-wave Optimisation in Cardiac Resynchronisation Therapy Study

Not Applicable
Completed
Conditions
Heart Failure, Systolic
Registration Number
NCT02080000
Lead Sponsor
The Royal Bournemouth Hospital
Brief Summary

The aim of this study is to investigate whether the use of a simple feature on the 12 lead electrocardiogram (ECG) to optimise pacemaker device programming can have clinically relevant benefit to patient management. More specifically it is to investigate whether using the R-wave in V1 of the surface ECG to guide the timings between left (LV) and right ventricular (RV) pacing improves response to Cardiac Resynchronisation Therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Quality of Life Score3 months
Secondary Outcome Measures
NameTimeMethod
Left Ventricular End Systolic Volume Index3 months
6 minute hall walk distance3 months

Trial Locations

Locations (1)

Royal Bournemouth Hospital

🇬🇧

Bournemouth, Dorset, United Kingdom

Royal Bournemouth Hospital
🇬🇧Bournemouth, Dorset, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.